{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:38:00Z","timestamp":1740166680885,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41429-024-00791-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:06:15Z","timestamp":1732781175000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolation and identification of three new isomer impurities in milbemycin oxime drug substance"],"prefix":"10.1038","volume":"78","author":[{"given":"Xiaohan","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yefei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-5055","authenticated-orcid":false,"given":"Huan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"791_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12934-017-0626-8","volume":"16","author":"MS Kim","year":"2017","unstructured":"Kim MS, Cho WJ, Song MC, Park SW, Kim K, Kim E, et al. Engineered biosynthesis of milbemycins in the avermectin high-producing strain Streptomyces avermitilis. Micro Cell Fact. 2017;16:9.","journal-title":"Micro Cell Fact"},{"key":"791_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-4017(94)00743-V","volume":"59","author":"WL Shoop","year":"1995","unstructured":"Shoop WL, Mrozik H, Fisher MH. Structure and activity of avermectins and milbemycins in animal health. Vet Parasitol. 1995;59:139\u201356.","journal-title":"Vet Parasitol"},{"key":"791_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7164\/antibiotics.41.519","volume":"41","author":"GT Carter","year":"1988","unstructured":"Carter GT, Nietsche JA, Hertz MR, Williams DR, Siegel MM. LL-F28249 antibiotic complex: a new family of antiparasitic macrocyclic lactones. J Antibiot. 1988;41:519\u201329.","journal-title":"J Antibiot"},{"key":"791_CR4","doi-asserted-by":"crossref","unstructured":"Takiguchi Y, Mishima H, Okuda M, Terao M, Aoki A, Fukuda R. Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties. J Antibiot. 2006;33:1120\u20137.","DOI":"10.7164\/antibiotics.33.1120"},{"key":"791_CR5","doi-asserted-by":"crossref","unstructured":"Wang HY, Liu YQ, Cheng X, Zhang YY, Li SS, Wang XJ, et al. Titer improvement of milbemycins via coordinating metabolic competition and transcriptional co-activation controlled by Streptomyces antibiotic regulatory protein family regulator in Streptomyces bingchenggensis. Biotechnol Bioeng. 2022;119:1252\u201363.","DOI":"10.1002\/bit.28044"},{"key":"791_CR6","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1007\/s00203-021-02575-1","volume":"203","author":"YS Yan","year":"2021","unstructured":"Yan YS, Xia HY. Recent advances in the research of milbemycin biosynthesis and regulation as well as strategies for strain improvement. Arch Micrbiol. 2021;203:5849\u201357.","journal-title":"Arch Micrbiol"},{"key":"791_CR7","doi-asserted-by":"crossref","unstructured":"Jung M, Saito A, Buescher G, Maurer M, Graf JF. Chemistry, pharmacology and safety: milbemycin oxime. In: Vercruysse J, Rew RS, editors. Macrocyclic lactones in antiparasitic therapy. New York: CABI Publishing; 2002. pp. 51\u201374.","DOI":"10.1079\/9780851996172.0051"},{"key":"791_CR8","unstructured":"European Medicines Agency. Milbemycin oxime for veterinary use monograph, European Pharmacopoeia. 10th ed. 2020. pp. 3272\u20135."},{"key":"791_CR9","unstructured":"US Pharmcopeial Convention. Milbemycin oxime monograph, USP40-NF-35. 2017. pp. 8819\u201321."},{"key":"791_CR10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.7164\/antibiotics.36.980","volume":"36","author":"H Mishima","year":"1983","unstructured":"Mishima H, Ide J, Muramatsu S, Ono M. Milbemycins, a new family of macrolide antibiotics. Structure determination of milbemycins D, E, F, G, H, J and K. J Antibiot. 1983;36:980\u201390.","journal-title":"J Antibiot"},{"key":"791_CR11","doi-asserted-by":"crossref","unstructured":"Ono M, Mishima H, Takiguchi Y, Terao M, Kobayashi H, Iwasaki S, et al. Milbemycins, a new family of macrolide antibiotics. Studies on the biosynthesis of milbemycins \u03b12, \u03b14 and D using 13C labeled precursors. J Antibiot. 1983;36:991\u20131000.","DOI":"10.7164\/antibiotics.36.991"},{"key":"791_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.7164\/antibiotics.36.438","volume":"36","author":"T Okazaki","year":"1983","unstructured":"Okazaki T, Ono M, Aoki A, Fukuda R. Milbemycins, a new family of macrolide antibiotics: producing organism and its mutants. J Antibiot. 1983;36:438\u201341.","journal-title":"J Antibiot"},{"key":"791_CR13","doi-asserted-by":"crossref","unstructured":"Tsukamoto Y, Sato K, Mio S, Sugai S, Yanai T, Kitano N, et al. Synthesis of 5-keto-5-oxime derivatives of milbemycins and their activities against microfilariae. Agric Biol Chem. 1991;55:2615\u201321.","DOI":"10.1080\/00021369.1991.10870993"},{"key":"791_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114862","volume":"217","author":"S Adhikari","year":"2022","unstructured":"Adhikari S, Rustum AM. Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR. J Pharm Biomed. 2022;217:114862.","journal-title":"J Pharm Biomed"},{"key":"791_CR15","first-page":"3108","volume":"11","author":"S Toranmal","year":"2019","unstructured":"Toranmal S, Buchade R, Tandale S, Wagh V, Chaure P. Development and validation of stability indicating HPLC method for simultaneous estimation of milbemycin oxime and praziquantel from bulk and marketed formulation. J Pharm Sci Res. 2019;11:3108\u201315.","journal-title":"J Pharm Sci Res"},{"key":"791_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10337-021-04028-9","volume":"84","author":"J Huang","year":"2021","unstructured":"Huang J, He J, Rustum AM. Development and validation of a stability-indicating HPLC method for assay of milbemycin oxime and estimation of its related compounds. Chromatographia. 2021;84:483\u201398.","journal-title":"Chromatographia"},{"key":"791_CR17","doi-asserted-by":"crossref","unstructured":"Letendre L, Harriman J, Drag M, Mullins A, Malinski T, Rehbein S. The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs. J Vet Pharm Ther. 2017;40:35\u201343.","DOI":"10.1111\/jvp.12332"},{"key":"791_CR18","unstructured":"ICH Guidelines, Q3A (R2), Impurities in new drug substances. In: The International Council On Harmonisation Of Technical Requirements for Pharmaceuticals For Human Use, Geneva. 2006."},{"key":"791_CR19","doi-asserted-by":"crossref","unstructured":"Zhang H, Zhang SY, Zhang J, Qi H, Wang H, Zhang LQ, et al. Acyltransferase domain swapping for the production of tenvermectin B metabolites in genetically engineered strain streptomyces avermitilis HU02. J Agric Food Chem. 2022;70:11994\u20132003.","DOI":"10.1021\/acs.jafc.2c04482"},{"key":"791_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1271\/bbb.61.806","volume":"61","author":"Y Tsukamoto","year":"1997","unstructured":"Tsukamoto Y, Kajino H, Sato K, Tanaka KJ, Yanai T. Synthesis of 24a-substituted milbemycin A4 derivatives and their acaricidal activity against Tetranychus urticae. Biosci Biotechnol Biochem. 1997;61:806\u201312.","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00791-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T23:03:11Z","timestamp":1737932591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1038\/s41429-024-00791-7","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"type":"print","value":"0021-8820"},{"type":"electronic","value":"1881-1469"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}